Placeholder Banner

FOX Business: BIO CEO Jim Greenwood Discusses State of the Industry

May 7, 2015
BIO President and CEO Jim Greenwood recently appeared on Fox Business Risk & Reward with Deirdre Bolton to discuss the current state of the industry.

Greenwood quickly debunked the “bubble” rumor by explaining the index continues to move up year over year and it is driven by strong science that results in strong returns and that increasing sophistication among investors allows them to more accurately assess company valuations than in the past. Further, Greenwood addressed the strength of innovation in emerging biotech companies and the synergies created by collaboration with traditional big pharmas, which has resulted in a cocmpetitive investment landscape and what some might term a "health ecosystem."



To conclude, Greenwood argued that the National Institutes of Health (NIH) plays a critical role in advancing basic research, and that adequate funding support for the NIH is critical in the quest to find new treatments and cures.